Astria Therapeutics, Inc. (ATXS)
12.94
0.00 (0.00%)
USD |
NASDAQ |
Dec 15, 16:00
12.94
0.00 (0.00%)
After-Hours: 19:56
Astria Therapeutics Research and Development Expense (Quarterly): 24.15M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 44.27M |
| Johnson & Johnson | 3.693B |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| CorMedix, Inc. | 5.098M |
| Rezolute, Inc. | 13.15M |